封面
市場調查報告書
商品編碼
1981042

全球青光眼手術器械市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Glaucoma Surgery Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 136 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計青光眼手術器械的市場規模將從 2025 年的 25.8 億美元成長到 2034 年的 196 億美元,2026 年至 2034 年的複合年成長率為 25.27%。

由於青光眼發生率不斷上升,全球青光眼手術器械市場正經歷顯著成長。青光眼是全球不可逆性失明的主要原因之一。青光眼手術器械用於降低眼內壓,防止視神經進一步受損。早期診斷和手術介入對於控制病情進展至關重要。

技術進步正在改變青光眼的治療選擇,尤其是微創青光眼手術(MIGS)設備。這些創新設備使外科醫生能夠進行更安全、創傷更小的手術,並縮短患者的康復時間。眼科診所和醫院對先進眼科技術的日益普及正在推動市場成長。

隨著全球人口老化和青光眼高發生風險持續存在,青光眼手術設備市場前景依然強勁。篩檢計畫的改進和眼健康意識的提高將進一步推動手術治療的需求。眼科設備的持續創新將有助於改善治療效果並擴大市場機會。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球青光眼手術器械市場:依手術類型分類

  • 市場分析、洞察與預測
  • 傳統青光眼手術
  • 微創青光眼手術

第5章 全球青光眼手術器械市場:依產品分類

  • 市場分析、洞察與預測
  • 植入和支架
  • 青光眼引流裝置
  • 青光眼雷射設備

第6章 全球青光眼手術器械市場:依最終使用者分類

  • 市場分析、洞察與預測
  • 眼科醫院和眼科診所
  • 門診手術中心
  • 門診手術中心

第7章 全球青光眼手術器材市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbvie Inc.(Allergan)
    • Alcon Inc
    • Glaukos Corporation
    • Johnson & Johnson(Abbott Medical Optics)
    • IStar Medical SA
    • Lumibird Medical(Ellex Medical Lasers Ltd)
    • Lumenis Ltd
    • New World Medical Inc
    • Santen Pharmaceutical Co. Ltd
    • Topcon Corporation
簡介目錄
Product Code: VMR112115635

The Glaucoma Surgery Devices Market size is expected to reach USD 19.60 Billion in 2034 from USD 2.58 Billion (2025) growing at a CAGR of 25.27% during 2026-2034.

The global glaucoma surgery devices market is witnessing significant growth due to the increasing prevalence of glaucoma, a major cause of irreversible blindness worldwide. Glaucoma surgery devices are used to reduce intraocular pressure and prevent further damage to the optic nerve. Early diagnosis and surgical intervention are essential for managing the progression of the disease.

Technological advancements are transforming glaucoma treatment options, particularly through minimally invasive glaucoma surgery (MIGS) devices. These innovative devices allow surgeons to perform safer and less invasive procedures with faster recovery times for patients. The increasing adoption of advanced ophthalmic technologies in eye care clinics and hospitals is supporting market growth.

Future prospects for the glaucoma surgery devices market remain strong as aging populations continue to increase the risk of glaucoma worldwide. Improved screening programs and growing awareness about eye health will further drive demand for surgical treatments. Continuous innovation in ophthalmic devices will help improve treatment outcomes and expand market opportunities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Surgery Type

  • Conventional Glaucoma Surgeries
  • Minimally Invasive Glaucoma Surgeries

By Product

  • Implants & Stents
  • Glaucoma Drainage Devices
  • Glaucoma Laser Devices

By End User

  • Eye Hospital & Ophthalmology Clinic
  • Ambulatory Surgical Centers (ASCS)
  • Outpatient Surgical Centers

COMPANIES PROFILED

  • Abbvie Inc Allergan, Alcon Inc, Glaukos Corporation, Johnson Johnson Abbott Medical Optics, iStar Medical SA, Lumibird Medical Ellex Medical Lasers Ltd, Lumenis Ltd, New World Medical Inc, Santen Pharmaceutical Co Ltd, Topcon Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY SURGERY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Surgery Type
  • 4.2. Conventional Glaucoma Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Minimally Invasive Glaucoma Surgeries Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Implants & Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Glaucoma Drainage Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Glaucoma Laser Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Eye Hospital & Ophthalmology Clinic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers (ASCS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Outpatient Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GLAUCOMA SURGERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Surgery Type
    • 7.2.2 By Product
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Surgery Type
    • 7.3.2 By Product
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Surgery Type
    • 7.4.2 By Product
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Surgery Type
    • 7.5.2 By Product
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Surgery Type
    • 7.6.2 By Product
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL GLAUCOMA SURGERY DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbvie Inc. (Allergan)
    • 9.2.2 Alcon Inc
    • 9.2.3 Glaukos Corporation
    • 9.2.4 Johnson & Johnson (Abbott Medical Optics)
    • 9.2.5 IStar Medical SA
    • 9.2.6 Lumibird Medical (Ellex Medical Lasers Ltd)
    • 9.2.7 Lumenis Ltd
    • 9.2.8 New World Medical Inc
    • 9.2.9 Santen Pharmaceutical Co. Ltd
    • 9.2.10 Topcon Corporation